Page last updated: 2024-08-24

3,5-di-tert-butylcatechol and Anesthesia Related Hyperthermia

3,5-di-tert-butylcatechol has been researched along with Anesthesia Related Hyperthermia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fusi, F; Höller, C; Kraft, B; Kress, HG; Lacava, C; Michalek-Sauberer, A; Sgaragli, G; Sipos, E; Weigl, LG	1

Other Studies

1 other study(ies) available for 3,5-di-tert-butylcatechol and Anesthesia Related Hyperthermia

Article	Year
3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility. Pharmacological research, 2012, Volume: 66, Issue:1 Topics: Caffeine; Calcium; Calcium Channel Agonists; Catechols; Cells, Cultured; Dose-Response Relationship, Drug; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction; Muscle Fibers, Skeletal; Predictive Value of Tests; Risk Assessment; Risk Factors; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Time Factors	2012

Article

Year

3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.

Pharmacological research, 2012, Volume: 66, Issue:1

Topics: Caffeine; Calcium; Calcium Channel Agonists; Catechols; Cells, Cultured; Dose-Response Relationship, Drug; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction; Muscle Fibers, Skeletal; Predictive Value of Tests; Risk Assessment; Risk Factors; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Time Factors

2012